958 results on '"Abbott, Kevin"'
Search Results
52. PD21-11 PREVALENCE OF URINARY INCONTINENCE AMONG A NATIONALLY REPRESENTATIVE SAMPLE OF ADULT WOMEN: FINDINGS FROM THE UROLOGIC DISEASES IN AMERICA PROJECT
53. PD29-04 EVOLUTION OF HEALTHCARE COSTS FOR LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
54. PD32-01 NATIONAL PRESCRIBING TRENDS AMONG ADULTS WITH URINARY TRACT INFECTIONS: FINDINGS FROM THE UROLOGIC DISEASES IN AMERICA PROJECT
55. MP65-18 BURDEN, TREATMENT, AND COST OF HYPOSPADIAS IN THE UNITED STATES: FINDINGS FROM THE UROLOGIC DISEASES IN AMERICA PROJECT
56. PD29-08 POOR CLINICAL GUIDELINE ADHERENCE AND INAPPROPRIATE TESTING IN MEN WITH INCIDENT LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA
57. MP27-04 ECONOMIC COST OF URINARY INCONTINENCE FOR INSURED ADULT MEN IN THE UNITED STATES: FINDINGS FROM THE UROLOGICAL DISEASES IN AMERICA PROJECT
58. MP27-03 ECONOMIC COST OF URINARY INCONTINENCE FOR INSURED ADULT WOMEN IN THE UNITED STATES, 2004-2013
59. PD56-03 NATIONAL SURGICAL TRENDS IN LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
60. MP43-19 PERSISTENTLY HIGH LEVELS OF OPIOID UTILIZATION AMONG PATIENTS WITH URINARY STONE DISEASE
61. PD33-06 NATIONAL PRESCRIBING TRENDS IN LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
62. Abstract P182: Diet Quality and Longitudinal Change in Kidney Function: Findings From the Hispanic Community Health Study/Study of Latinos (hchs/sol)
63. Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States
64. US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States
65. Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients
66. An analysis of hot spots of ESRD in the United States: Potential presence of CKD of unknown origin in the USA?
67. Rate of Kidney Function Decline Associates with Mortality
68. Arteriovenous Fistulas among Incident Hemodialysis Patients in Department of Defense and Veterans Affairs Facilities
69. Reply
70. Leasing and development in the Marcellus shale region: avoiding the pitfalls.
71. Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation
72. Observation time after kidney biopsy: when to discharge?
73. Survival advantages of obesity in dialysis patients2–3
74. Differing Manifestations of Hepatitis C and Tacrolimus on Hospitalized Diabetes Mellitus Occurring after Kidney Transplantation
75. Oral Sodium Phosphate Drug Products and Renal Function
76. The prevalence of BK polyomavirus infection in outpatient kidney transplant recipients followed in a single center
77. A new supine anterolateral approach to percutaneous ultrasound-guided renal biopsy
78. Association of Oral Sodium Phosphate Purgative Use with Acute Kidney Injury
79. Medication Compliance in Transplantation
80. Body Mass Index and Peritoneal Dialysis: “Exceptions to the Exception” in Reverse Epidemiology?
81. Chapter 23 Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction
82. Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients*
83. Agreement of Immunosuppression Regimens Described in Medicare Pharmacy Claims with the Organ Procurement and Transplantation Network Survey
84. Thrombotic microangiopathy in United States long-term dialysis patients
85. Therapeutic Plasma Exchange as a Nephrological Procedure: A Single-Center Experience
86. The Life-Years Saved by a Deceased Organ Donor
87. Response to ‘Viral Hepatitis Guidelines for Transplant Recipients’
88. Preservation of Renal Structure and Function at 2 Years without Calcineurin Inhibitor Use
89. Update on Guidelines for Prevention and Management of Mycobacterium Tuberculosis Infections After Transplant
90. Late urinary tract infection after renal transplantation in the United States
91. Survival advantages of obesity in dialysis patients1-4
92. Early renal insufficiency and late venous thromboembolism after renal transplantation in the united states
93. What have we learned from the current trials?
94. β-Blocker Use in Long-term Dialysis Patients: Association With Hospitalized Heart Failure and Mortality
95. The Impact of Transplantation with Deceased Donor Hepatitis C-Positive Kidneys on Survival in Wait-Listed Long-term Dialysis Patients
96. Impact of Diabetes and Hepatitis after Kidney Transplantation on Patients Who Are Affected by Hepatitis C Virus
97. Mycobacterium Tuberculosis Infection Incidence in Hospitalized Renal Transplant Patients in the United States, 1998–2000
98. Human Immunodeficiency Virus Infection and Kidney Transplantation in the Era of Highly Active Antiretroviral Therapy and Modern Immunosuppression
99. Blood Pressure Control and Nephroprotection in Diabetes
100. Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.